Skip to main content

What the FDA labels say about taking them together

Cyclopentolate and pilocarpine

Cyclopentolate's FDA label of June 25, 2024 names pilocarpine in its drug interactions section; the pilocarpine labels PlainMeds reads (3) do not name cyclopentolate.

Check it at the source: the cyclopentolate FDA label on DailyMed (effective June 25, 2024, Alcon Laboratories, Inc.); the pilocarpine FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the cyclopentolate label say about pilocarpine?

Cyclopentolate label, drug interactions

Drug Interactions: Cyclopentolate may interfere with the ocular anti-hypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Source: FDA drug label (Cyclogyl), Alcon Laboratories, Inc., effective June 25, 2024 (SPL set 1d008c76-7210-4ace-90fa-7cd22762e12e), via openFDA; the full label on DailyMed

What does the pilocarpine label say about cyclopentolate?

Pilocarpine's label (effective December 5, 2024) and its 2 other brand-application labels do not name cyclopentolate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Salagen), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set 62eda83d-d043-4c7e-8fcf-75d05efbf35b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Cyclopentolate generic labelers
7Pilocarpine generic labelers
CyclopentolatePilocarpine
Labeled forn/aGlaucoma
Boxed warningNoNo
Pharmacy cost (NADAC)$2.65 per mL 1% eye drops$0.338 per tablet 5 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?